Variant report
Variant | nsv974255 |
---|---|
Chromosome Location | chr13:92767278-92791534 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:1)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:1 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr13:92777089..92778054-chr2:189460184..189460902,2 | MCF-7 | breast: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs188060923 | chr13:92772035-92772036 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs192551944 | chr13:92772102-92772103 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs531081397 | chr13:92772110-92772111 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs73626585 | chr13:92772135-92772136 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs372742472 | chr13:92772136-92772137 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs9560926 | chr13:92772171-92772172 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
7 | rs549088109 | chr13:92772206-92772207 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs148373060 | chr13:92772260-92772261 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs562888691 | chr13:92772270-92772271 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs116371808 | chr13:92772286-92772287 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs377354930 | chr13:92772328-92772329 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs557589951 | chr13:92772402-92772403 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs182365250 | chr13:92772414-92772415 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs527401465 | chr13:92772447-92772448 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs9301779 | chr13:92772499-92772500 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
16 | rs556723154 | chr13:92772597-92772598 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs146355640 | chr13:92772598-92772599 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs559138768 | chr13:92774268-92774269 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs575697939 | chr13:92774278-92774279 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs538250434 | chr13:92774319-92774320 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs144530355 | chr13:92774327-92774328 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs575097633 | chr13:92774333-92774334 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs147813239 | chr13:92774337-92774338 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs540437088 | chr13:92774343-92774344 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs184662855 | chr13:92774362-92774363 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs577070794 | chr13:92774380-92774381 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs553102778 | chr13:92786036-92786037 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs530237136 | chr13:92786050-92786051 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs146254003 | chr13:92786079-92786080 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs567775988 | chr13:92786114-92786115 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs536777350 | chr13:92786123-92786124 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs573109597 | chr13:92786152-92786153 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs191604371 | chr13:92786208-92786209 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs184139054 | chr13:92786209-92786210 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs189684041 | chr13:92786213-92786214 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs558993663 | chr13:92786255-92786256 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs540715164 | chr13:92786265-92786266 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs575750646 | chr13:92786311-92786312 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs546034640 | chr13:92786384-92786385 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs139589162 | chr13:92786417-92786418 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs556608035 | chr13:92786428-92786429 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs192711108 | chr13:92786437-92786438 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs542342853 | chr13:92786454-92786455 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs558920154 | chr13:92786491-92786492 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs572792472 | chr13:92786588-92786589 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs185160176 | chr13:92786634-92786635 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs565053738 | chr13:92786664-92786665 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs563884998 | chr13:92786666-92786667 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs532767335 | chr13:92786667-92786668 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs530695491 | chr13:92786716-92786717 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Prostate cancer | 16705090 | CNVD |
High-proliferative meningiomas | 17937814 | CNVD |
Cancer | 20164919 | CNVD |
Autism | 22495311 | CNVD |
Chordoma | 21602918 | CNVD |
Bladder cancer | 21949216 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Cancer | 21637783 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Chronic lymphocytic leukemia | 21518781 | CNVD |
colon cancer | 17210682 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Ovarian cancer | 20844748 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Intracranial aneurysm | 19064780 | CNVD |
Breast cancer | 19287154 | CNVD |
Acute myeloid leukemia | 18379011 | CNVD |
Human rectal carcinomas | 16397240 | CNVD |
Olfactory neuroblastoma | 18408657 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Ependymoma | 16718352 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Breast cancer | 16608533 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Myoepithelioma | 18604193 | CNVD |
Breast cancer | 17133270 | CNVD |
Prostate cancer | 18632612 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Melanoma | 18172304 | CNVD |
Prostate cancer | 16573809 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Gastric cancer | 17908304 | CNVD |
Splenic marginal zone lymphoma | 18492102 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Non-syndromic sensorineural hearing loss | 20606397 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Prostate cancer | 21965145 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Cancer | 21220470 | CNVD |
Cancer | 21183584 | CNVD |
Omodysplasia | 19481194 | CNVD |
Breast cancer | 22032731 | CNVD |
Mantle cell lymphoma | 19690137 | CNVD |
Rhabdomyosarcoma | 17210683 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Breast cancer | 21364760 | CNVD |
Medulloblastoma | 19270706 | CNVD |
Myelofibrosis | 22110671 | CNVD |
coloboma | 21285886 | CNVD |
Cancer | 20164920 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Wilms tumour | 21544195 | CNVD |
Acute myeloid leukemia | 19651601 | CNVD |
Effusion lymphoma | 18079361 | CNVD |
Developmental delay | 21147756 | CNVD |
Melanoma | 20877625 | CNVD |
Colorectal cancer | 21645411 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Breast cancer | 22522925 | CNVD |
early-passage human iPS cells | 21368824 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr13:92772000-92772600 | Enhancers | Fetal Heart | heart |
2 | chr13:92774200-92774400 | Enhancers | Fetal Heart | heart |
3 | chr13:92786000-92787600 | Enhancers | Adipose Nuclei | Adipose |
4 | chr13:92786200-92787200 | Enhancers | Liver | Liver |
5 | chr13:92787200-92788200 | Flanking Active TSS | Liver | Liver |
6 | chr13:92787400-92787600 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
7 | chr13:92787400-92788000 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
8 | chr13:92787400-92788200 | Enhancers | HepG2 | liver |
9 | chr13:92787600-92787800 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
10 | chr13:92787600-92789000 | Weak transcription | Adipose Nuclei | Adipose |
11 | chr13:92788000-92789000 | Weak transcription | Fetal Adrenal Gland | Adrenal Gland |
12 | chr13:92788200-92789200 | Weak transcription | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
13 | chr13:92788200-92789600 | Enhancers | Liver | Liver |
14 | chr13:92789000-92789400 | Enhancers | Fetal Brain Male | brain |
15 | chr13:92789000-92790000 | Enhancers | Adipose Nuclei | Adipose |
16 | chr13:92789200-92789400 | Enhancers | Fetal Adrenal Gland | Adrenal Gland |
17 | chr13:92789200-92789600 | Enhancers | hESC Derived CD56+ Mesoderm Cultured Cells | ES cell derived |
18 | chr13:92789200-92789600 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
19 | chr13:92789200-92789600 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
20 | chr13:92789600-92789800 | Flanking Active TSS | Liver | Liver |
21 | chr13:92789800-92790200 | Enhancers | Liver | Liver |
22 | chr13:92790200-92795400 | Weak transcription | Liver | Liver |